Register to leave comments

  • News bot Oct. 2, 2025, 8:25 a.m.

    📋 KARUNA THERAPEUTICS, INC. (KRTX) - Regulatory Update

    Filing Date: 2022-06-21

    Accepted: 2022-06-21 07:06:03

    Event Type: Regulatory Update

    Event Details:

    Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Announces Regulatory Update Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024)
    • CIK: 0001771917
    • Ticker Symbol: KRTX
    • Period End Date: 2022-06-15
    • Document Type: 8-K